Schedule 13D ownership disclosure
ADAPTIMMUNE THERAPEUTICS PLC
Security class unavailable · CUSIP: 00653A107
Event date: 2023-03-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-23-000276
- Form type
- SC 13D
- Filer
- Adaptimmune Therapeutics PLC
- CIK
- CIK 1621227
- Filed
- Mar 30, 2023
- Reporting period
- Mar 05, 2023
- Description
- Schedule 13D beneficial ownership